Drug Repurposing: New Treatments for Zika Virus Infection?

Trends Mol Med. 2016 Nov;22(11):919-921. doi: 10.1016/j.molmed.2016.09.006. Epub 2016 Sep 28.

Abstract

To date, no antiviral agents have been approved for treating Zika virus (ZIKV) infection. Two recent drug-repurposing studies published in Cell Host & Microbe and Nature Medicine demonstrated that screening FDA-approved drugs for antiviral activity is a promising strategy for identifying therapeutics with novel activity against ZIKV infection.

Keywords: Zika virus; antiviral; drug repurposing; mechanism-of-action.

MeSH terms

  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use*
  • Drug Repositioning / methods*
  • Humans
  • Signal Transduction / drug effects
  • Zika Virus / drug effects*
  • Zika Virus Infection / drug therapy*
  • Zika Virus Infection / metabolism

Substances

  • Antiviral Agents